These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 37548539)

  • 1. The Genetic, Pharmacogenomic, and Immune Landscapes Associated with Protein Expression across Human Cancers.
    Chen C; Liu Y; Li Q; Zhang Z; Luo M; Liu Y; Han L
    Cancer Res; 2023 Nov; 83(22):3673-3680. PubMed ID: 37548539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic, Pharmacogenomic, and Immune Landscapes of Enhancer RNAs Across Human Cancers.
    Zhang Z; Luo M; Li Q; Liu Y; Lussier C; Zhang J; Ye Y; Guo AY; Han L
    Cancer Res; 2022 Mar; 82(5):785-790. PubMed ID: 35022213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetic and pharmacogenomic landscape of snoRNAs in human cancer.
    Liu Y; Ruan H; Li S; Ye Y; Hong W; Gong J; Zhang Z; Jing Y; Zhang X; Diao L; Han L
    Mol Cancer; 2020 Jun; 19(1):108. PubMed ID: 32576192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CancerImmunityQTL: a database to systematically evaluate the impact of genetic variants on immune infiltration in human cancer.
    Tian J; Cai Y; Li Y; Lu Z; Huang J; Deng Y; Yang N; Wang X; Ying P; Zhang S; Zhu Y; Zhang H; Zhong R; Chang J; Miao X
    Nucleic Acids Res; 2021 Jan; 49(D1):D1065-D1073. PubMed ID: 33010176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-cancer analysis of promoter activity quantitative trait loci.
    Li R; Wan D; Liang J; Liang H; Huang H; Li G
    NAR Cancer; 2023 Dec; 5(4):zcad053. PubMed ID: 38023732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic control of the human brain proteome.
    Robins C; Liu Y; Fan W; Duong DM; Meigs J; Harerimana NV; Gerasimov ES; Dammer EB; Cutler DJ; Beach TG; Reiman EM; De Jager PL; Bennett DA; Lah JJ; Wingo AP; Levey AI; Seyfried NT; Wingo TS
    Am J Hum Genet; 2021 Mar; 108(3):400-410. PubMed ID: 33571421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapy.
    Stark AL; Hause RJ; Gorsic LK; Antao NN; Wong SS; Chung SH; Gill DF; Im HK; Myers JL; White KP; Jones RB; Dolan ME
    PLoS Genet; 2014 Apr; 10(4):e1004192. PubMed ID: 24699359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPEdit: the genetic and pharmacogenomic landscape of A-to-I RNA editing in cancers.
    Ruan H; Li Q; Liu Y; Liu Y; Lussier C; Diao L; Han L
    Nucleic Acids Res; 2022 Jan; 50(D1):D1231-D1237. PubMed ID: 34534336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Explore, Visualize, and Analyze Functional Cancer Proteomic Data Using the Cancer Proteome Atlas.
    Li J; Akbani R; Zhao W; Lu Y; Weinstein JN; Mills GB; Liang H
    Cancer Res; 2017 Nov; 77(21):e51-e54. PubMed ID: 29092939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PancanQTLv2.0: a comprehensive resource for expression quantitative trait loci across human cancers.
    Chen C; Liu Y; Luo M; Yang J; Chen Y; Wang R; Zhou J; Zang Y; Diao L; Han L
    Nucleic Acids Res; 2024 Jan; 52(D1):D1400-D1406. PubMed ID: 37870463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-Cancer Analysis of Microbiome Quantitative Trait Loci.
    Chen C; Cai Y; Liu Y; Chen S; Li Y; Zhang F; Zhang M; Lu Z; Ying P; Huang J; Fan L; Cai X; Ning C; Wang W; Jiang Y; Zhang H; Yang S; Wang Z; Wang X; Zhang S; Huang C; Xu B; Fu Z; Song Q; Jin M; Chen K; Chen H; Dai M; Miao X; Yang X; Zhu Y; Tian J
    Cancer Res; 2022 Oct; 82(19):3449-3456. PubMed ID: 35972351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
    Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
    Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma proteomic associations with genetics and health in the UK Biobank.
    Sun BB; Chiou J; Traylor M; Benner C; Hsu YH; Richardson TG; Surendran P; Mahajan A; Robins C; Vasquez-Grinnell SG; Hou L; Kvikstad EM; Burren OS; Davitte J; Ferber KL; Gillies CE; Hedman ÅK; Hu S; Lin T; Mikkilineni R; Pendergrass RK; Pickering C; Prins B; Baird D; Chen CY; Ward LD; Deaton AM; Welsh S; Willis CM; Lehner N; Arnold M; Wörheide MA; Suhre K; Kastenmüller G; Sethi A; Cule M; Raj A; ; ; ; ; ; ; ; ; ; Burkitt-Gray L; Melamud E; Black MH; Fauman EB; Howson JMM; Kang HM; McCarthy MI; Nioi P; Petrovski S; Scott RA; Smith EN; Szalma S; Waterworth DM; Mitnaul LJ; Szustakowski JD; Gibson BW; Miller MR; Whelan CD
    Nature; 2023 Oct; 622(7982):329-338. PubMed ID: 37794186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
    Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
    Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive molecular and clinical characterization of SLC1A5 in human cancers.
    Zhang H; Cui K; Yao S; Yin Y; Liu D; Huang Z
    Pathol Res Pract; 2021 Aug; 224():153525. PubMed ID: 34171602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HGH1 and the immune landscape: a novel prognostic marker for immune-desert tumor microenvironment identification and immunotherapy outcome prediction in human cancers.
    Wu G; Dong Y; Hu Q; Ma H; Xu Q; Xu K; Chen H; Yang Z; He M
    Cell Cycle; 2023 Sep; 22(18):1969-1985. PubMed ID: 37811868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Throughput Characterization of Blood Serum Proteomics of IBD Patients with Respect to Aging and Genetic Factors.
    Di Narzo AF; Telesco SE; Brodmerkel C; Argmann C; Peters LA; Li K; Kidd B; Dudley J; Cho J; Schadt EE; Kasarskis A; Dobrin R; Hao K
    PLoS Genet; 2017 Jan; 13(1):e1006565. PubMed ID: 28129359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Common and Rare Genetic Variation Associated With Plasma Protein Levels Using Whole-Exome Sequencing and Mass Spectrometry.
    Solomon T; Lapek JD; Jensen SB; Greenwald WW; Hindberg K; Matsui H; Latysheva N; Braekken SK; Gonzalez DJ; Frazer KA; Smith EN; Hansen JB
    Circ Genom Precis Med; 2018 Dec; 11(12):e002170. PubMed ID: 30562114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels.
    Liu CJ; Hu FF; Xie GY; Miao YR; Li XW; Zeng Y; Guo AY
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36549921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCAS: An Integrated Tool for Multi-Dimensional Cancer Research Utilizing Clinical Proteomic Tumor Analysis Consortium Data.
    Wang J; Song X; Wei M; Qin L; Zhu Q; Wang S; Liang T; Hu W; Zhu X; Li J
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.